DE · AFX.DE
Carl Zeiss Meditec AG
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Jena 07745
- Website
- zeiss.de
Price · as of 2025-09-30
$26.48
Market cap 2.26B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $42.56 | +60.73% |
| Intrinsic Value(DCF) | $16.23 | -38.71% |
| Graham-Dodd Method(GD) | $12.17 | -54.06% |
| Graham Formula(GF) | $25.15 | -5.02% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $12.50 | $32.52 | $2.81 | $2.17 | $17.60 |
| 2012 | $18.94 | $32.25 | $14.28 | $6.48 | $18.68 |
| 2013 | $21.35 | $36.13 | $0.00 | $6.85 | $15.07 |
| 2014 | $18.38 | $31.75 | $0.00 | $4.70 | $7.85 |
| 2015 | $26.95 | $36.90 | $0.00 | $5.08 | $16.78 |
| 2016 | $32.41 | $36.85 | $0.00 | $8.13 | $15.15 |
| 2017 | $48.92 | $50.02 | $0.00 | $13.43 | $26.90 |
| 2018 | $67.78 | $53.45 | $0.00 | $11.21 | $21.77 |
| 2019 | $106.55 | $71.52 | $5.11 | $12.54 | $38.44 |
| 2020 | $105.29 | $67.15 | $0.00 | $9.37 | $0.13 |
| 2021 | $178.35 | $103.77 | $2.87 | $20.59 | $80.61 |
| 2022 | $113.83 | $83.29 | $9.55 | $20.66 | $75.75 |
| 2023 | $95.48 | $68.51 | $21.73 | $19.23 | $56.83 |
| 2024 | $48.85 | $44.67 | $0.00 | $5.40 | $14.05 |
| 2025 | $40.58 | $42.56 | $0.00 | $12.17 | $25.15 |
AI valuation
Our deep-learning model estimates Carl Zeiss Meditec AG's (AFX.DE) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $42.56
- Current price
- $26.48
- AI upside
- +60.73%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$16.23
-38.71% upside
Graham-Dodd
$12.17
-54.06% upside
Graham Formula
$25.15
-5.02% upside
About Carl Zeiss Meditec AG
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
- CEO
- Andreas Pecher
- Employees
- 2.07K
- Beta
- 1.44
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($16.23 ÷ $26.48) − 1 = -38.71% (DCF, example).